A female-led preclinical biotech start-up, Vitarka Therapeutics is focused on revolutionising the market for non-viral drug delivery technology. The company is developing combination medicines using RNAi therapies and a non-viral drug delivery platform. Their novel tumour-targeted platform technology, EndoPore, targets solid tumours and delivers therapeutics for intracellular targets. 

Founded in 2013, YAFO Capital is a Shanghai based boutique investment & advisory firm focusing on bringing global technologies to Asia. We started from investing in Israeli Medtech to China back to 2013, YAFO has established four joint ventures with our global partners in Japan, Italy, Germany, and Switzerland.

YAFO has four pillar business lines including: investment banking, fund investment, incubation, and biotech forum .

YAFO, the Hebrew word of Jaffa (now part of Tel Aviv), means beautiful. For 3500 years, the old Jaffa port has connected the ancient city with the rest of the world.

YAFO’s mission is to make our life more beautiful by introducing global technologies.